lianhuaqingwen
Botanicalexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
2
Earliest trial started May 8, 2022 (NCT05366231)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05625035 | Phase 4 | Nov 1, 2022 | Shandong University |
| NCT06355193 | Phase 1 | Nov 1, 2022 | Central South University |
| NCT05366231 | Phase 4 | May 8, 2022 | Baili Pharmaceutical Group, Fudan University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baili Pharmaceutical Group | For profit | 1 | 1 | 1 | 2022 |
| Central South University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Shandong University | Academic/Hospital | 1 | 1 | 1 | 2022 |
4 organizations
Page 1 / 1